Regeneus Ltd (ASX:RGS) Receives Innovation Grant
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, has received $50K in funding as part of the Innovation Connections Grant from the Australian Government's Department of Industry, Innovation and Science.